Human Health Holdings Limited (HKG:1419)
Hong Kong
· Delayed Price · Currency is HKD 0.8300
0.00 (0.00%)
Jun 13, 2025, 9:55 AM HKT
Human Health Holdings Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 611.42 | 590.82 | 1,002 | 1,122 | 654.71 | 453.74 | Upgrade
|
| Revenue Growth (YoY) | -0.69% | -41.02% | -10.70% | 71.34% | 44.29% | -14.16% | Upgrade
|
| Cost of Revenue | 333.35 | 320.97 | 408.51 | 462.11 | 278.02 | 263.9 | Upgrade
|
| Gross Profit | 278.06 | 269.85 | 593.24 | 659.69 | 376.69 | 189.84 | Upgrade
|
| Selling, General & Admin | 191.59 | 184.47 | 211.18 | 166.7 | 152.37 | 133.09 | Upgrade
|
| Operating Expenses | 258.54 | 251.7 | 286.16 | 230.88 | 230.63 | 208.43 | Upgrade
|
| Operating Income | 19.52 | 18.15 | 307.07 | 428.81 | 146.06 | -18.59 | Upgrade
|
| Interest Expense | -7.18 | -8.22 | -8.3 | -2.93 | -2.93 | -4.69 | Upgrade
|
| Interest & Investment Income | 16.52 | 17.15 | 8.49 | 0.2 | 0.29 | 1.66 | Upgrade
|
| Earnings From Equity Investments | -0.69 | -1.27 | -1.54 | -1.98 | 0.99 | -1.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.17 | 1.34 | 2.51 | 0.82 | 0.14 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | 29.35 | 27.15 | 308.23 | 424.92 | 144.55 | -22.74 | Upgrade
|
| Gain (Loss) on Sale of Investments | 11.91 | 16.58 | -6.27 | 25.52 | 2.63 | -25.8 | Upgrade
|
| Asset Writedown | -18.56 | -17.16 | -63.15 | -10 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 4.82 | 21.63 | 9.53 | Upgrade
|
| Pretax Income | 22.7 | 26.56 | 238.82 | 445.26 | 168.82 | -39.01 | Upgrade
|
| Income Tax Expense | 1.72 | 2.38 | 57.98 | 69.95 | 24.37 | 1.36 | Upgrade
|
| Earnings From Continuing Operations | 20.98 | 24.19 | 180.84 | 375.31 | 144.45 | -40.37 | Upgrade
|
| Net Income | 20.98 | 24.19 | 180.84 | 375.31 | 144.45 | -40.37 | Upgrade
|
| Net Income to Common | 20.98 | 24.19 | 180.84 | 375.31 | 144.45 | -40.37 | Upgrade
|
| Net Income Growth | - | -86.62% | -51.82% | 159.81% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 380 | 380 | 380 | 380 | 380 | 380 | Upgrade
|
| Shares Outstanding (Diluted) | 380 | 380 | 380 | 380 | 380 | 380 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | - | 2.16% | Upgrade
|
| EPS (Basic) | 0.06 | 0.06 | 0.48 | 0.99 | 0.38 | -0.11 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.06 | 0.48 | 0.99 | 0.38 | -0.11 | Upgrade
|
| EPS Growth | - | -86.61% | -51.86% | 159.81% | - | - | Upgrade
|
| Free Cash Flow | 70.43 | -26.3 | 580.24 | 219.3 | 71.44 | 26.03 | Upgrade
|
| Free Cash Flow Per Share | 0.19 | -0.07 | 1.53 | 0.58 | 0.19 | 0.07 | Upgrade
|
| Dividend Per Share | 0.028 | 0.028 | 0.160 | 0.300 | 0.120 | - | Upgrade
|
| Dividend Growth | -82.50% | -82.50% | -46.67% | 150.00% | - | - | Upgrade
|
| Gross Margin | 45.48% | 45.67% | 59.22% | 58.81% | 57.54% | 41.84% | Upgrade
|
| Operating Margin | 3.19% | 3.07% | 30.65% | 38.22% | 22.31% | -4.10% | Upgrade
|
| Profit Margin | 3.43% | 4.09% | 18.05% | 33.46% | 22.06% | -8.90% | Upgrade
|
| Free Cash Flow Margin | 11.52% | -4.45% | 57.92% | 19.55% | 10.91% | 5.74% | Upgrade
|
| EBITDA | 40.16 | 39.07 | 323.46 | 437.63 | 155.85 | -8.09 | Upgrade
|
| EBITDA Margin | 6.57% | 6.61% | 32.29% | 39.01% | 23.80% | -1.78% | Upgrade
|
| D&A For EBITDA | 20.63 | 20.92 | 16.39 | 8.83 | 9.79 | 10.5 | Upgrade
|
| EBIT | 19.52 | 18.15 | 307.07 | 428.81 | 146.06 | -18.59 | Upgrade
|
| EBIT Margin | 3.19% | 3.07% | 30.65% | 38.22% | 22.31% | -4.10% | Upgrade
|
| Effective Tax Rate | 7.57% | 8.94% | 24.28% | 15.71% | 14.43% | - | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.